Article Details

AstraZeneca invests in Imperial's self-amplifying RNA technology with eye on future drugs

Retrieved on: 2021-09-23 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca invests in Imperial's self-amplifying RNA technology with eye on future drugs. View article details on hiswai:

Excerpt

By Alistair Smout. LONDON (Reuters) - AstraZeneca Plc on Thursday struck a deal with the firm behind Imperial College London's experimental COVID-19 vaccine ...

Article found on: uk.sports.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up